Mikhail Eydelman Vaxcyte, Inc. (PCVX) insider trading activity

Mikhail Eydelman is SVP, GEN COUNSEL & CORP SEC of Vaxcyte, Inc.. Currently has a direct ownership of 41,620 shares of PCVX, which is worth approximately $1.37 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 5,000 shares (Common Stock) at a price of $71.28 per share, resulting in proceeds of $356,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.6K

47.47% 3M change

36.03% 12M change

Total Value Held $1.37 Million

Mikhail Eydelman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	SELL Open market or private sale	$356,400 $71.28 p/Share	5,000 Reduced 10.73%	41,620 Common Stock
Mar 05 2025	BUY Exercise of conversion of derivative security	$107,050 $21.41 p/Share	5,000 Added 9.69%	46,620 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$44,413 $72.1 p/Share	616 Reduced 1.46%	41,620 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$34,319 $73.02 p/Share	470 Reduced 1.1%	42,236 Common Stock
Feb 27 2025	BUY Grant, award, or other acquisition	-	14,484 Added 25.33%	42,706 Common Stock
Feb 05 2025	SELL Open market or private sale	$449,550 $89.91 p/Share	5,000 Reduced 15.05%	28,222 Common Stock
Feb 05 2025	BUY Exercise of conversion of derivative security	$107,050 $21.41 p/Share	5,000 Added 13.08%	33,222 Common Stock
Jan 06 2025	SELL Open market or private sale	$428,500 $85.7 p/Share	5,000 Reduced 15.05%	28,222 Common Stock
Jan 06 2025	BUY Exercise of conversion of derivative security	$107,050 $21.41 p/Share	5,000 Added 13.08%	33,222 Common Stock
Dec 09 2024	SELL Payment of exercise price or tax liability	$43,728 $92.06 p/Share	475 Reduced 1.66%	28,222 Common Stock
Dec 05 2024	SELL Bona fide gift	-	110 Reduced 0.38%	28,697 Common Stock
Dec 05 2024	SELL Open market or private sale	$458,300 $91.66 p/Share	5,000 Reduced 14.84%	28,697 Common Stock
Dec 05 2024	BUY Exercise of conversion of derivative security	$107,050 $21.41 p/Share	5,000 Added 12.92%	33,697 Common Stock
Nov 05 2024	SELL Open market or private sale	$531,050 $106.21 p/Share	5,000 Reduced 14.87%	28,623 Common Stock
Nov 05 2024	BUY Exercise of conversion of derivative security	$107,050 $21.41 p/Share	5,000 Added 12.95%	33,623 Common Stock
Oct 07 2024	SELL Open market or private sale	$547,950 $109.59 p/Share	5,000 Reduced 14.87%	28,623 Common Stock
Oct 07 2024	BUY Exercise of conversion of derivative security	$107,050 $21.41 p/Share	5,000 Added 12.95%	33,623 Common Stock
Oct 01 2024	SELL Open market or private sale	$628,375 $114.25 p/Share	5,500 Reduced 16.12%	28,623 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$117,755 $21.41 p/Share	5,500 Added 13.88%	34,123 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$242,660 $110.15 p/Share	2,203 Reduced 7.15%	28,623 Common Stock
Sep 03 2024	SELL Open market or private sale	$188,270 $112.94 p/Share	1,667 Reduced 5.13%	30,826 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$35,690 $21.41 p/Share	1,667 Added 4.88%	32,493 Common Stock
Aug 01 2024	SELL Open market or private sale	$131,776 $79.05 p/Share	1,667 Reduced 5.13%	30,826 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$35,690 $21.41 p/Share	1,667 Added 4.88%	32,493 Common Stock
Jul 01 2024	SELL Open market or private sale	$127,392 $76.42 p/Share	1,667 Reduced 5.13%	30,826 Common Stock

Mikhail Eydelman

SVP, GEN COUNSEL & CORP SEC

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account